[ Inside the business ]

ALB stock analysis

ALB · Albemarle Corp

Plastic materials, synth resins and nonvulcan elastomers. Growing 19%. Keeps 10¢ of every dollar.

Watch: growth that has stopped speeding up.

The future, in 7 questions

Priced in: 0.6× sales in 5 yrs. Evidence: sales +19% · 10¢ profit/$1 · Sodium-ion batteries rising.

01 What's priced in?0.6× sales in 5 yrs
Sales now$6.2B
Needed in 5 yrs$3.8B
02 Is the wave rising?Sodium-ion batteries · 3.2×
'20'21'22'23'24'2516
#5 of 15 mentioning it
03 Will customers keep buying?Sales +19%, steady
No customer over 10%
Prepaid $371MSales +19%, steady
04 Is it scarce?Some signs
PricingBacklogPrepaidSell-outTight
05 More profit per sale?Keeps 10¢ per $1, rising
'21'22'23'24'2510¢
Before running costs: 42% → 13%
06 Can it fund itself?Pays its own way
05 yrsself-funded
Shares −0.0%/yrDebt $1.9B
07 What could break it?2 to watch
  • Growth slowing
  • Moves strongly with the S&P 500

From SEC filings, price and Radar. Not advice.

The record

Early signals

Growth slowing.

Sales growth +33%, +31%, then +19% vs. a year ago.

What could go wrong

Falls harder.

It has moved 1.5× the market. In the 2008 crisis it fell 59% while the market fell 51%. Debt is moderate.

Speculative check

Self-funding.

Passes every condition: profitable, cash-generating and financially sound.

What they sell

Not broken out.

The filings don't split revenue by product in structured data.

Where each dollar goes

10¢ profit.

74¢ to make what it sells, 16¢ on research and overhead, 10¢ left over. Revenue $6.2B in the last 12 months.

Its market

1.1× the economy.

The government expects its industry, chemical manufacturing, to grow 2.2% a year to 2035, vs. 2.0% for the whole economy.

Market size and share

Your call.

There's no official size for its market. Enter one you trust to see its share, and slide to see what a bigger share would mean.

Life cycle

Shake-out.

Its cash flows are mixed, typical of a company in transition.

Earnings quality

Clean.

Its numbers don't resemble those of past manipulators. Cash covers 271¢ of each $1 of profit.

Competitive advantage

2 of 10 years.

Returns beat its 9.5% cost of capital in 2 of the last 10 years. Gross margin went from 36% to 13%.

Future bets

1% on research.

$33M a year on R&D. $406M on equipment and buildings.

All figures from Albemarle Corp's SEC filings (EDGAR) unless tagged otherwise. Educational only, not investment advice.